NHS agrees to bankroll Batten disease drug
News Previous     Next

NHS agrees to bankroll Batten disease drug

The NHS has agreed to fund a medicine for children with a rare degenerative disease. NHS England has announced that an agreement on price had been struck with the drug’s manufacturer Biomarin.

Learning Disability Practice. 22, 5, 7-7. doi: 10.7748/ldp.22.5.7.s4

You need a subscription to read the full article